Results 151 to 160 of about 350,201 (281)

Gastrointestinal Manifestations in Rubinstein‐Taybi Syndrome

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Rubinstein–Taybi syndrome is a rare genetic condition associated with a wide range of physical, cognitive, and developmental impairments, yet its gastrointestinal manifestations remain poorly characterized. Case reports and small series suggest a high prevalence of gastroesophageal reflux, constipation, dysphagia, and nutritional compromise ...
Mohamad Abi Nassif, Ajay Kaul, Lev Dorfman, Khalil El‐Chammas   +3 more
wiley   +1 more source

Which PPI? [PDF]

Gut, 2001
openaire   +2 more sources

Quantitative proteomics identifies clusterin as a novel biomarker for atherosclerosis

Animal Models and Experimental Medicine, EarlyView.
This schematic illustrates the proposed mechanism. In advanced atherosclerotic lesions, upregulated CLU on the cell surface activates low‐density lipoprotein (LDL) receptor‐related protein 1 (LRP1). This interaction triggers the phosphorylation and activation of AKT.
Dengfeng Ding, Yingjie Zhang, Li Zhang, Xinou Zheng, Miaomiao Niu, Yunxiao Jia, Xuezhuang Li, Hua Chen, Chao Guo, Tao Jiang, Yuqiong Zhao   +10 more
wiley   +1 more source

A comprehensive proteome and phosphoproteome atlas across nine organs of the Chinese hamster

Animal Models and Experimental Medicine, EarlyView.
This study presents the first comprehensive proteome and phosphoproteome atlas of the Chinese hamster across nine organs (heart, liver, lung, kidney, spleen, cerebral cortex, skeletal muscle, stomach, and testis or ovary). A total of 14 219 proteins were identified in the proteome, with 11 828 phosphorylated proteins and 47 122 phosphorylation sites ...
Luyao Zhang, Tao Ding, Wanjun Peng, Jie Kong, Xiaoyue Tang, Jiyu Xu, Qiaochu Wang, Zhiyi Zhang, Chunmei Shi, Yizhuo Tian, Huilan Yang, Yehong Yang, Yue Wu, Xiaoyan Liu, Jiangfeng Liu, Juntao Yang   +15 more
wiley   +1 more source

Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signatures. [PDF]

Cancer Immunol Immunother
Petouhoff A, Hicks R, Husain M, Hoyd R, Xu M, Dravillas C, Patel SH, Johns A, Grogan M, Li M, Lopez G, Miah A, Liu Y, Muniak M, Schmidt M, Das A, Lathrop H, Das P, Secor A, Haddad T, Tinoco G, Carbone D, Kendra K, Otterson GA, Presley CJ, Mace T, Spakowicz D, Owen DH.   +27 more
europepmc   +1 more source

GP perspectives on a computer-assisted strategy to support PPI deprescribing: a qualitative study. [PDF]

Sci Rep
Kornder N, Bücker B, Schmidt A, Reichert W, Löscher S, Maas M, Barzel A, Becker A, Wilm S, Viniol A, Heisig J.   +10 more
europepmc   +1 more source

Takotsubo syndrome in the setting of cardiac pacing: A review of mechanistic and clinical perspectives. [PDF]

Heart Fail Rev
Yalta K, Ozkan U, Yetkin E.
europepmc   +1 more source

Appropriate prescribing and deprescribing of proton pump inhibitors: New Choosing Wisely Canada toolkit. [PDF]

Can Fam Physician
Bland E, van Zanten SV, Thompson W.
europepmc   +1 more source

Microsecond Dynamics of the Pyrophosphate Ion Release in SARS-CoV‑2 RNA Polymerase. [PDF]

JACS Au
Xu T, Yang L, Xu X, Zhang BY, Gao X, Ishbashi T, Gong P, Cheung PP, Zhang L.   +8 more
europepmc   +1 more source

Knochenbrecher PPI? [PDF]

CME, 2010
openaire   +1 more source